Title: Impact of Prolonging CMV Prophylaxis in High Risk (CMV D+/R-) Lung Transplant Recipients
Abstract: CMV seronegative recipients receiving a seropositive allograft (D+/R-) are at a high risk of developing CMV disease. Our program increased the duration of CMV prophylaxis from 6 to 9 months in high risk patients from May 2013 onwards. Here, we present the impact of the change in our protocol on the incidence of CMV infection, disease, and side effects.
Publication Year: 2017
Publication Date: 2017-04-01
Language: en
Type: article
Indexed In: ['crossref']
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot